No results found for “”
No results found for filter “”
-
Statements & press releases 13.01.22
EFPIA statement on a GDPR Code of Conduct
A GDPR Code of conduct will enable the sector to align on key data protection positions, thereby providing more consistency, more clarity and more certainty...
Read Article -
EFPIA News 11.01.22
Stronger Intellectual Property Rights in EU Free Trade Agreements can boost GDP, productivity, investments...
Discover a recent ECIPE report, supported by EFPIA among other industry associations.
Read Article -
EFPIA News 06.01.22
EFPIA publishes the Evidence MIX (Measures, Insights and eXamples) Report
Evaluating the EU Regulatory System, Assessing the Environment, Gaining Direct Experimental Insights, and Offering Policy Recommendations from Innovative...
Read Article -
Statements & press releases 04.01.22
EFPIA Press Release welcoming the French Presidency of the Council of the EU
As the French Presidency of the Council begins, it is time for Europe to back innovation and boost access to medicines.
Read Article -
Statements & press releases 17.12.21
Industry response to the Northern Ireland Protocol proposals
The European Commission and UK Government have taken significant practical steps towards resolving outstanding issues with the regulation and supply of...
Read Article -
Blog articles 15.12.21
Patient Think Tank – Why Bother? (Guest blog)
It’s an inspiring and motivating place to be!
Read Article -
Statements & press releases 14.12.21
EFPIA statement on adoption of Health Technology Assessment Regulation
EFPIA stands ready to play its part to ensure that the future system for joint clinical assessments delivers for patients and that the objective of timely...
Read Article -
Blog articles 14.12.21
The evolution of the EFPIA Patient Think Tank over the last fifteen years (Guest blog)
In the last few years, the EFPIA Patient Think Tank, alongside addressing relevant policy topics, has helped to grow and accompany EFPIA’s wider patient...
Read Article -
Blog articles 14.12.21
The right of being involved in health research a worldwide right for children (Guest blog)
When these activities refer to children and young people, to guarantee their active engagement for co-designing patient centric initiatives it’s essential...
Read Article -
Blog articles 14.12.21
Why is Lupus Europe part of the EFPIA Patient Think Tank? (Guest blog)
As a member of the PTT, we can give our lupus patient perspective to pharmaceutical projects, early on, and hopefully influence and direct R&D to meet...
Read Article -
Blog articles 13.12.21
It’s time to Power Up health systems
Five key dimensions should be the guide when reforming and investing in our health systems: People, Outcomes, Workforce, Efficiency and Resilience.
Read Article -
Blog articles 08.12.21
Aligning the European Pharmaceutical Industry on a quality approach for industry funded and led Lifelong...
Discover the new EFPIA guideline for its member companies.
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 11.01.22
Stronger Intellectual Property Rights in EU Free Trade Agreements can boost GDP, productivity, investments...
Discover a recent ECIPE report, supported by EFPIA among other industry associations.
Read Article -
EFPIA News 06.01.22
EFPIA publishes the Evidence MIX (Measures, Insights and eXamples) Report
Evaluating the EU Regulatory System, Assessing the Environment, Gaining Direct Experimental Insights, and Offering Policy Recommendations from Innovative...
Read Article -
EFPIA News 07.12.21
EFPIA response to EPSCO discussion on Strengthening the European Health Union
EFPIA thanks the Slovenian Presidency for its commitment to advancing the EU healthcare debate, and looks forward to working with all stakeholders under...
Read Article -
EFPIA News 19.11.21
Industry partners welcome adoption of Innovative Health Initiative
The Innovative Health Initiative is a unique cross-sectoral initiative aiming at strengthening Europe’s position at the forefront of health innovation....
Read Article -
EFPIA News 15.11.21
Financing environment of biopharmaceutical SMEs in Europe
Take 10 minutes to fill in our survey
Read Article -
EFPIA News 12.11.21
The Impact of Pharmaceutical IP Provisions in EU Free Trade Agreements
This report examines the impact of past EU FTAs on drug spending, timing of countries’ access to new medicines after global launch, investments overall...
Read Article -
EFPIA News 03.12.20
Working together towards better patient outcomes
A new series of short films to showcase innovative partnerships that will change patient outcomes
Read Article -
EFPIA News 14.10.20
Biopharmaceutical industry support EU regulators exceptional transparency measures
And call other regulatory authorities to follow suit to help ensure confidence in the science and the decision-making
Read Article -
EFPIA News 17.09.20
Vaccines Europe Statement on the safety of COVID-19 vaccines
The health and safety of people receiving any vaccine is our first priority, and that applies equally to recipients of a COVID-19 vaccine
Read Article -
EFPIA News 10.06.20
Connecting Healthcare Awards - Submission period extended
The new deadline is 30 September 2020
Read Article -
EFPIA News 23.04.20
Europe’s COVID-19 battle: Getting the data we need to ensure the supply of medicines
A major part of the solution is the provision of detailed, accurate forecasting data from the European Centre for Disease Control (ECDC) on the patient-level...
Read Article -
EFPIA News 22.04.20
Coronavirus – your questions answered
What is the industry in Europe doing to help in the fight against the coronavirus? What are the risks of drug shortage caused by the coronavirus?
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 13.01.22
EFPIA statement on a GDPR Code of Conduct
A GDPR Code of conduct will enable the sector to align on key data protection positions, thereby providing more consistency, more clarity and more certainty...
Read Article -
Statements & press releases 04.01.22
EFPIA Press Release welcoming the French Presidency of the Council of the EU
As the French Presidency of the Council begins, it is time for Europe to back innovation and boost access to medicines.
Read Article -
Statements & press releases 17.12.21
Industry response to the Northern Ireland Protocol proposals
The European Commission and UK Government have taken significant practical steps towards resolving outstanding issues with the regulation and supply of...
Read Article -
Statements & press releases 14.12.21
EFPIA statement on adoption of Health Technology Assessment Regulation
EFPIA stands ready to play its part to ensure that the future system for joint clinical assessments delivers for patients and that the objective of timely...
Read Article -
Statements & press releases 29.11.21
EFPIA - Vaccines Europe statement on Omicron variant
Working with the broader scientific community, public health and regulatory bodies around the world, our industry will continue to bring that experience...
Read Article -
Statements & press releases 26.11.21
The European Commission and Innovative Biopharmaceutical Industries to Explore Potential Initiatives...
This initiative has brought together a diverse range of continental and international stakeholders to collaborate in the drive to increase the continent's...
Read Article -
Statements & press releases 25.11.21
A once-in-a-generation opportunity to optimise regulatory timelines to improve time to patient access...
Three potential solutions to optimise regulatory timelines
Read Article -
Statements & press releases 24.11.21
Access today and medical innovation for tomorrow
EFPIA welcomes the work done by the European Parliament on delivering a report on a Pharmaceutical Strategy for Europe, one of the pillars of the European...
Read Article -
Statements & press releases 17.11.21
EFPIA and Vaccines Europe position on the European Health Emergency preparedness and Response Authority...
While during the pandemic the EU reacted to issues as they arose, the creation of HERA is a first step to putting Europe on the front foot in addressing...
Read Article -
Statements & press releases 12.11.21
EFPIA Statement on the 11 November Foreign Affairs Council Meeting
The global biopharmaceutical industry supports a strong international trading system rooted in the WTO core principles of pursuing open borders, non-discriminatory...
Read Article -
Statements & press releases 28.10.21
Joint Industry Statement: ABPI, EFPIA, Farmindustria, IMC, IFPMA, JPMA, LEEM, PhRMA, vfa
UN Climate Change Conference (COP26): Biopharmaceutical Industry Actions to Tackle Climate Change
Read Article -
Statements & press releases 28.10.21
Supporting academic and non-for-profit champions to repurpose medicines
The EMA and several National Competent Authorities launch a new pilot project today
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 15.12.21
Patient Think Tank – Why Bother? (Guest blog)
It’s an inspiring and motivating place to be!
Read Article -
Blog articles 14.12.21
The evolution of the EFPIA Patient Think Tank over the last fifteen years (Guest blog)
In the last few years, the EFPIA Patient Think Tank, alongside addressing relevant policy topics, has helped to grow and accompany EFPIA’s wider patient...
Read Article -
Blog articles 14.12.21
The right of being involved in health research a worldwide right for children (Guest blog)
When these activities refer to children and young people, to guarantee their active engagement for co-designing patient centric initiatives it’s essential...
Read Article -
Blog articles 14.12.21
Why is Lupus Europe part of the EFPIA Patient Think Tank? (Guest blog)
As a member of the PTT, we can give our lupus patient perspective to pharmaceutical projects, early on, and hopefully influence and direct R&D to meet...
Read Article -
Blog articles 13.12.21
It’s time to Power Up health systems
Five key dimensions should be the guide when reforming and investing in our health systems: People, Outcomes, Workforce, Efficiency and Resilience.
Read Article -
Blog articles 08.12.21
Aligning the European Pharmaceutical Industry on a quality approach for industry funded and led Lifelong...
Discover the new EFPIA guideline for its member companies.
Read Article -
Blog articles 29.11.21
Achieving global vaccine equity and tackling new variants
Intellectual property is part of the solution to get the world vaccinated against COVID-19
Read Article -
Blog articles 22.11.21
Success with use of real world data in medicines research: Joining the dots of the European ecosystem...
Aside from inclusion in regulatory authority or other submissions, RWD can also facilitate medicines development e.g. by helping to understand the natural...
Read Article -
Blog articles 17.11.21
WTO Members Should Use Their Upcoming Ministerial To Improve Our Ability To Respond To A Health Crisis...
It’s become somewhat of a cliché to write that a global crisis requires a global answer. On health, we are convinced that the world has the means to provide...
Read Article -
Blog articles 09.11.21
Building a healthier and more environmentally sustainable future: a case-study from Takeda
The pharmaceutical industry contributes to a healthy environment while demonstrating leadership in mitigating climate change
Read Article -
Blog articles 02.11.21
Lung Cancer Awareness Month: The importance of the patient perspective in driving advancements in testing...
Reducing the burden of lung cancer and transforming long-term outcomes for patients
Read Article -
Blog articles 29.10.21
What does it take to get the world vaccinated against COVID-19?
The real path to global vaccine equity
Read Article